This in turn results in secondary hyperparathyroidism, as well as chronic inflammation causing increased production of pro-inflammatory cytokines in the mucosa and serum, particularly TNFα, IL-1, and IL-6 [11] disrupting bone growth and autoimmune factors. The gene discussed is IL1B; the disease is secondary hyperparathyroidism.